eMedicine Specialties > Emergency Medicine > Genitourinary

Renal Calculi: Differential Diagnoses & Workup

Author: Sandy Craig, MD, Adjunct Associate Professor, Department of Emergency Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center
Contributor Information and Disclosures

Updated: Oct 29, 2009

Differential Diagnoses

Aneurysm, Abdominal
Obstruction, Small Bowel
Aneurysm, Thoracic
Pancreatitis
Appendicitis, Acute
Papillary Necrosis
Back Pain, Mechanical
Pediatrics, Urinary Tract Infections and Pyelonephritis
Cholecystitis and Biliary Colic
Pelvic Inflammatory Disease
Cholelithiasis
Pneumonia, Bacterial
Constipation
Pneumothorax, Tension and Traumatic
Dissection, Aortic
Pregnancy, Ectopic
Diverticular Disease
Pregnancy, Urinary Tract Infections
Epididymitis
Renal Cell Carcinoma
Foreign Bodies, Gastrointestinal
Renal Vein Thrombosis
Foreign Bodies, Rectum
Testicular Torsion
Gastritis and Peptic Ulcer Disease
Torsion of the Appendices and Epididymis
Glomerulonephritis, Acute
Transplants, Renal
Herpes Zoster
Urinary Obstruction
Inflammatory Bowel Disease
Urinary Tract Infection, Female
Lumbar (Intervertebral) Disk Disorders
Urinary Tract Infection, Male
Obstruction, Large Bowel
Wilms Tumor

Other Problems to Be Considered

Pyonephrosis
Renal artery embolus

Workup

Laboratory Studies

  • Urinalysis
    • One retrospective study found that 67% of patients with ureterolithiasis had more than 5 RBC per high power field (hpf) and 89% of patients had more than 0 RBC/hpf on urine microscopic examination.7 In addition, 94.5% have hematuria if screened with microscopy plus urine dipstick testing.8
    • Degree of hematuria is not predictive of stone size or likelihood of passage.
    • No literature exists to support the theory that ureterolithiasis without hematuria is indicative of complete ureteral obstruction.
    • Pyuria (>5 WBC/hpf on a centrifuged specimen) in a patient with ureterolithiasis should prompt a careful search for signs of infected hydronephrosis. Obtain a complete blood count (CBC), creatinine, and urine culture. Treatment with antibiotics is indicated in patients with ureterolithiasis and pyuria. Admission to the hospital is mandatory if the patient has any signs of infected hydronephrosis (fever, elevated WBC count, elevated creatinine), or if follow-up within 24 hours is not reliably available.
    • A urine pH greater than 7 suggests presence of urea-splitting organisms, such as Proteus, Pseudomonas, or Klebsiella species, and struvite stones.
    • A urine pH less than 5 suggests uric acid stones.
  • Electrolytes
    • Serum creatinine level is the major predictor of contrast-induced nephrotoxicity.
    • If creatinine level is greater than 2 mg/dL, use diagnostic techniques that do not require an infusion of contrast, such as ultrasonography or helical CT scan.
    • Hypokalemia and decreased serum bicarbonate level suggest underlying distal (type 1) renal tubular acidosis, which is associated with formation of calcium phosphate stones.

Imaging Studies

  • Most authors recommend diagnostic imaging to confirm the diagnosis in first-time episodes of ureterolithiasis, when the diagnosis is unclear, or if associated proximal UTI is suspected. Lindqvist et al found that patients who are pain-free after receiving analgesics could be discharged from the ED and undergo radiologic imaging after 2-3 weeks without increasing morbidity.9
  • Kidney, ureter, and bladder (KUB) radiography
    • Multiple studies show that the KUB radiography has low (40-50%) sensitivity and specificity for the presence of ureterolithiasis and adds nothing to the emergent clinical impression. At follow-up, the urologist may find the KUB radiograph to be helpful in determining the exact size and shape of the stone, in establishing a baseline for follow-up studies, and for visualization of the surgical orientation.
    • KUB radiographs can be used to monitor passage of a previously documented opaque stone. Note that most stones will appear larger on KUB radiograph than on CT, with CT-based measurement of maximum stone dimension approximately 12% smaller compared with a KUB-based measurement.10
  • Computed tomography (CT): Noncontrast helical CT has become the criterion standard imaging study in the ED diagnosis of ureterolithiasis (see Media file 1).
Noncontrast helical CT scan of the abdomen demons...

Noncontrast helical CT scan of the abdomen demonstrating a stone at the right ureterovesical junction.

Noncontrast helical CT scan of the abdomen demons...

Noncontrast helical CT scan of the abdomen demonstrating a stone at the right ureterovesical junction.


    • Numerous studies have demonstrated that CT has a sensitivity of 95-100% and superior specificity and accuracy compared with the historic criterion standard, intravenous pyelogram (IVP).11
    • Other advantages of helical CT include rapid (<5 min) acquisition time, avoidance of intravenous (IV) contrast, and potential for diagnosis of other pathology including AAA, pancreatitis, appendicitis, ovarian disorders, diverticular disease, renal carcinoma, and biliary tract disorders.12
    • Principal disadvantages are that helical CT gives no information on renal function or degree of urinary obstruction. A recent study also demonstrated that stone size as measured on CT KUB correlates poorly with actual size of the stone measured after spontaneous passage.13 For this reason, caution should be used in counseling patients on the likelihood of spontaneous stone passage when stone size is determined using CT-based measurement.
    • Pure indinavir stones are radiolucent and may not be visualized well by helical CT scan. However, indinavir stones often serve as a nidus for deposition of calcium oxalate or calcium phosphate deposition and thus become radioopaque. CT KUB remains the test of choice for patients on indinavir who present with apparent renal colic.
    • Sulfadiazine stones, most often seen in AIDS patients taking sulfadiazine for treatment of toxoplasmosis, are also difficult to visualize on CT because of relatively low attenuation.14
  • Intravenous pyelogram: Prior to the advent of helical CT, IVP was the test of choice in diagnosing ureterolithiasis. IVP is widely available and fairly inexpensive but less sensitive than noncontrast helical CT.
    • Contrast is administered intravenously at a dose of 1 mL/kg, and KUB films are taken immediately and at 1, 5, 10, and 15 minutes until contrast fills both distal ureters (see Media file 2). Look for direct visualization of stone within the ureter, unilateral ureteral dilation, delayed appearance of the nephrogram phase, lack of normal peristalsis pattern of the ureter, or perirenal contrast extravasation. Degree of obstruction is graded based on delay in appearance of the nephrogram.
Intravenous pyelogram (IVP) demonstrating dilatio...

Intravenous pyelogram (IVP) demonstrating dilation of the right renal collecting system and right ureter consistent with right ureterovesical stone.

Intravenous pyelogram (IVP) demonstrating dilatio...

Intravenous pyelogram (IVP) demonstrating dilation of the right renal collecting system and right ureter consistent with right ureterovesical stone.


    • Anaphylaxis to ionic contrast agents (eg, Renografin, Conray) occurs in 1-2 patients per 1000 IVP studies. Risk of recurrence is approximately 15% if reexposed to ionic agents but falls to 5% when nonionic agents are used. Risk of anaphylaxis can be reduced further by pretreatment with a combination of H1- and H2-blockers and steroids, but studies showing the benefit of pretreatment began pretreatment more than 12 hours prior to study. Risk of nephrotoxicity is not clearly reduced with use of nonionic agents. Indications for use of nonionic contrast agents vary among institutions but consistently include history of prior mild to moderately severe reaction to ionic contrast, asthma, multiple allergies, or severe cardiac disease.
    • Disadvantages of IVP include radiation exposure and risk of nephrotoxicity or anaphylactoid reaction to contrast agent. IVP is relatively contraindicated in pregnant or dehydrated patients or if serum creatinine level exceeds 2 mg/dL. IVP is absolutely contraindicated in patients with a history of severe contrast-induced anaphylaxis. False-negative results usually occur with stones located at the ureterovesical junction.
  • Ultrasonography: This is a good imaging modality in patients who are pregnant or to rule out the presence of an AAA in patients older than 60 years with a first or atypical presentation of nephrolithiasis.15
    • A handful of small studies have found sensitivities of 65-100% (see Media files 3-4). Ultrasonography has been found to be less accurate in diagnosis of ureteral stones when compared with IVP or helical CT. Diagnostic criteria include direct visualization of the stone, hydroureter more than 6 mm in diameter, and perirenal urinoma suggesting calyceal rupture.11
Renal sonogram showing a dilated renal collecting...

Renal sonogram showing a dilated renal collecting system consistent with ureteral obstruction.

Renal sonogram showing a dilated renal collecting...

Renal sonogram showing a dilated renal collecting system consistent with ureteral obstruction.


Transabdominal sonogram revealing a ureteral ston...

Transabdominal sonogram revealing a ureteral stone at the ureterovesical junction.

Transabdominal sonogram revealing a ureteral ston...

Transabdominal sonogram revealing a ureteral stone at the ureterovesical junction.


    • Advantages include lack of radiation exposure and ability to complete the study at the bedside in patients who are potentially in unstable condition.
    • Disadvantages include inferior sensitivity, lack of universal availability, dependence on operator expertise, and inability to accurately estimate the degree of urinary obstruction.
    • A urine-filled bladder provides an excellent acoustic window for ultrasound imaging; sonograms occasionally may demonstrate a stone at the ureterovesical junction that is not seen on helical CT or IVP.
    • Future studies may utilize 2-dimensional ultrasonography in combination with color Doppler analysis of the ureteral jets to enhance sensitivity of ultrasonography in patients with ureteral colic.16
  • Magnetic resonance imaging: MRI can be used to detect ureteral stones. One study of 40 consecutive patients with acute flank pain found sensitivity of 54-58% and specificity of 100% using breath-hold heavily T2-weighted sequences.17 Sensitivity and specificity increased to 96.2-100% and 100%, respectively, using gadolinium-enhanced 3-D FLASH MR urography. Although MRI does not play a major role in the diagnosis of ureteral stones, lack of radiation makes MRI a good choice in pregnant women who have nondiagnostic findings from a sonogram.

Procedures

  • Occasionally, a patient may require urinary catheterization to relieve retention due to extreme pain or an obstructing bladder neck stone.

More on Renal Calculi

Overview: Renal Calculi
Differential Diagnoses & Workup: Renal Calculi
Treatment & Medication: Renal Calculi
Follow-up: Renal Calculi
Multimedia: Renal Calculi
References

References

  1. Worcester EM, Coe FL. Nephrolithiasis. Prim Care. Jun 2008;35(2):369-91, vii. [Medline].

  2. Chandhoke PS. Evaluation of the recurrent stone former. Urol Clin North Am. Aug 2007;34(3):315-22. [Medline].

  3. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. Jan 10 2002;346(2):77-84. [Medline].

  4. Russinko PJ, Agarwal S, Choi MJ, Kelty PJ. Obstructive nephropathy secondary to sulfasalazine calculi. Urology. Oct 2003;62(4):748. [Medline].

  5. Thomas A, Woodard C, Rovner ES, Wein AJ. Urologic complications of nonurologic medications. Urol Clin North Am. Feb 2003;30(1):123-31. [Medline].

  6. Whelan C, Schwartz BF. Bilateral guaifenesin ureteral calculi. Urology. Jan 2004;63(1):175-6. [Medline].

  7. Bove P, Kaplan D, Dalrymple N, et al. Reexamining the value of hematuria testing in patients with acute flank pain. J Urol. Sep 1999;162(3 Pt 1):685-7. [Medline].

  8. Press SM, Smith AD. Incidence of negative hematuria in patients with acute urinary lithiasis presenting to the emergency room with flank pain. Urology. May 1995;45(5):753-7. [Medline].

  9. Lindqvist K, Hellstrom M, Holmberg G, et al. Immediate versus deferred radiological investigation after acute renal colic: a prospective randomized study. Scand J Urol Nephrol. 2006;40(2):119-24. [Medline].

  10. Dundee P, Bouchier-Hayes D, Haxhimolla H, et al. Renal tract calculi: comparison of stone size on plain radiography and noncontrast spiral CT scan. J Endourol. Dec 2006;20(12):1005-9. [Medline].

  11. Jindal G, Ramchandani P. Acute flank pain secondary to urolithiasis: radiologic evaluation and alternate diagnoses. Radiol Clin North Am. May 2007;45(3):395-410, vii. [Medline].

  12. Neville A, Hatem SF. Renal medullary carcinoma: unsuspected diagnosis at stone protocol CT. Emerg Radiol. Sep 2007;14(4):245-7. [Medline].

  13. Kishore TA, Pedro RN, Hinck B, Monga M. Estimation of size of distal ureteral stones: noncontrast CT scan versus actual size. Urology. Oct 2008;72(4):761-4. [Medline].

  14. Dusseault BN, Croce KJ, Pais VM Jr. Radiographic characteristics of sulfadiazine urolithiasis. Urology. Apr 2009;73(4):928.e5-6. [Medline].

  15. Pais VM Jr, Payton AL, LaGrange CA. Urolithiasis in pregnancy. Urol Clin North Am. Feb 2007;34(1):43-52. [Medline].

  16. Cauni V, Multescu R, Geavlete P, Geavlete B. [The importance of Doppler ultrasonographic evaluation of the ureteral jets in patients with obstructive upper urinary tract lithiasis]. Chirurgia (Bucur). Nov-Dec 2008;103(6):665-8. [Medline].

  17. Sudah M, Vanninen R, Partanen K, et al. MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography. Fast low-angle shot. AJR Am J Roentgenol. Jan 2001;176(1):105-12. [Medline].

  18. Springhart WP, Marguet CG, Sur RL, et al. Forced versus minimal intravenous hydration in the management of acute renal colic: a randomized trial. J Endourol. Oct 2006;20(10):713-6. [Medline].

  19. Labrecque M, Dostaler LP, Rousselle R, et al. Efficacy of nonsteroidal anti-inflammatory drugs in the treatment of acute renal colic. A meta-analysis. Arch Intern Med. Jun 27 1994;154(12):1381-7. [Medline].

  20. Larkin GL, Peacock WF 4th, Pearl SM, et al. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med. Jan 1999;17(1):6-10. [Medline].

  21. Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol. Dec 2003;170(6 Pt 1):2202-5. [Medline].

  22. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol. Jul 2005;174(1):167-72. [Medline].

  23. Porpiglia F, Ghignone G, Fiori C, et al. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol. Aug 2004;172(2):568-71. [Medline].

  24. [Best Evidence] Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med. Nov 2007;50(5):552-63. [Medline].

  25. Beach MA, Mauro LS. Pharmacologic expulsive treatment of ureteral calculi. Ann Pharmacother. Jul-Aug 2006;40(7-8):1361-8. [Medline].

  26. Ferre RM, Wasielewski JN, Strout TD, Perron AD. Tamsulosin for ureteral stones in the emergency department: a randomized, controlled trial. Ann Emerg Med. Sep 2009;54(3):432-9, 439.e1-2. [Medline].

  27. Mariappan P, Loong CW. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol. Jun 2004;171(6 Pt 1):2142-5. [Medline].

  28. St Lezin M, Hofmann R, Stoller ML. Pyonephrosis: diagnosis and treatment. Br J Urol. Oct 1992;70(4):360-3. [Medline].

  29. Jeffrey RB, Laing FC, Wing VW. Sensitivity of sonography in pyonephrosis: a reevaluation. AJR Am J Roentgenol. Jan 1985;144(1):71-3. [Medline].

  30. Schneider K, Helmig FJ, Eife R. Pyonephrosis in childhood--is ultrasound sufficient for diagnosis?. Pediatr Radiol. 1989;19(5):302-7. [Medline].

  31. Fultz PJ, Hampton WR, Totterman SM. Computed tomography of pyonephrosis. Abdom Imaging. 1993;18(1):82-7. [Medline].

  32. Wu TT, Lee YH, Tzeng WS, et al. The role of C-reactive protein and erythrocyte sedimentation rate in the diagnosis of infected hydronephrosis and pyonephrosis. J Urol. Jul 1994;152(1):26-8. [Medline].

  33. Wen CC, Nakada SY. Treatment selection and outcomes: renal calculi. Urol Clin North Am. Aug 2007;34(3):409-19. [Medline].

  34. Ramakumar S, Segura JW. Renal calculi. Percutaneous management. Urol Clin North Am. Nov 2000;27(4):617-22. [Medline].

  35. Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ. May 9 2006;174(10):1407-9. [Medline].

  36. Borrero E, Queral LA. Symptomatic abdominal aortic aneurysm misdiagnosed as nephroureterolithiasis. Ann Vasc Surg. Apr 1988;2(2):145-9. [Medline].

  37. Sidhu R, Bhatt S, Dogra V. Renal Colic. Ultrasound Clinics. Jan 2008;3:159-170.

  38. Venkat A, Piontkowsky DM, Cooney RR, et al. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy. Ann Emerg Med. Sep 2008;52(3):274-85. [Medline].

Further Reading

Keywords

kidney stone symptoms, kidney stone causes, kidney stone treatment, renal calculi, kidney stone, renal stone, ureteral calculi, nephrolithiasis, ureterolithiasis, kidney calculi, acute nephrolithiasis

Contributor Information and Disclosures

Author

Sandy Craig, MD, Adjunct Associate Professor, Department of Emergency Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center
Sandy Craig, MD is a member of the following medical societies: Alpha Omega Alpha and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

David S Howes, MD, Residency Program Director, Professor of Medicine, Section of Emergency Medicine, University of Chicago/Pritzker School of Medicine
David S Howes, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Physicians-American Society of Internal Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Richard H Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System
Robert E O'Connor, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physician Executives, American Heart Association, American Medical Association, Medical Society of Delaware, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.